Zantac Heartburn Medication
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication Zantac exposes users to unsafe levels of the carcinogen N-Nitrosodimethylamine (NDMA). (Dimesky et al v. Sanofi-Aventis U.S., LLC, Sanofi US Services Inc., Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-1517, D. CT.)
Class-Action Tracker
The Latest
US Patent and Trademark Office Impersonator Reported to FTC
MADISON, CONN. Feb. 11, 2026 – A company calling itself “Patent & Trademark Office” is violating the FTC’s Impersonation Rule as well as the FTC Act by falsely posing as…
TINA.org Takes Action against Trademark Imposter Scam
Complaint to FTC cites violations of agency’s Impersonation Rule.
Linda & Rachel Boutique
TINA.org digs into shop’s purported Newport roots, and more.
Home Depot’s Rental Damage Protection Fee
TINA.org staffer gets surprise charge.
U-Haul Taking a Bite Out of the Big Apple
TINA.org files complaint with NYC over company’s “$19.95” truck rentals.